Safety and Efficacy of Regadenoson for Pediatric Stress Perfusion Cardiac MRI with Quantification of Myocardial Blood Flow

被引:3
|
作者
Patel, Shivani G. [1 ,2 ]
Husain, Nazia [1 ,2 ]
Rigsby, Cynthia K. [2 ,3 ,4 ]
Robinson, Joshua D. [1 ,2 ,4 ]
机构
[1] Ann & Robert H Lurie Childrens Hosp Chicago, Div Cardiol, Chicago, IL 60611 USA
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA
[3] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Med Imaging, Chicago, IL 60611 USA
[4] Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA
来源
CHILDREN-BASEL | 2022年 / 9卷 / 09期
关键词
pediatric; stress perfusion MRI; regadenoson; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; EMISSION COMPUTED-TOMOGRAPHY; RESERVE;
D O I
10.3390/children9091332
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Myocardial stress perfusion magnetic resonance imaging is a non-invasive tool to assess for myocardial ischemia and viability. Pediatric myocardial stress perfusion MRI can be challenging due to multiple intravenous lines, sedation, inadequate breath holding, fast heart rates, and complex anatomy. We performed a retrospective analysis in 39 children to evaluate safety and efficacy of regadenoson, a coronary vasodilator administered via a single intravenous line (6-10 mcg/kg), with respiratory motion correction (MOCO) and semi-quantitative blood flow analysis. Stress response data and adverse events were recorded, and image quality compared between native and MOCO reconstructions, assessing for perfusion deficits. Semi-quantitative analysis compared myocardial perfusion reserve index (MPRI) between patients who had a focal perfusion defect, patients who had undergone an orthotopic heart transplant, and non-transplant patients with no focal defects. Stress perfusion was completed in 38/39 patients (median age 15 years with a 41 +/- 27% rise in heart rate (p < 0.005). Fifteen out of thirty-eight had transient minor side effects with no major adverse events. MOCO image quality was better than non-MOCO (4.63 vs. 4.01 at rest, p < 0.005: 4.41 vs. 3.84 at stress, p < 0.005). Reversible perfusion defects were seen in 4/38 patients with lower segmental mean MPRI in the area of the perfusion defect, nearing statistical significance when compared to non-transplant patients with no defects (0.78 +/- 0.22 vs. 0.99 +/- 0.36, p = 0.07). The global MPRI of the 16 patients who had undergone orthotopic heart transplant was significantly lower than the non-transplant patients (0.75 +/- 0.22 vs. 0.92 +/- 0.23, p = 0.03). Regadenoson is a safe and effective coronary vasodilator for pediatric stress perfusion MRI with MOCO producing better image quality and allowing for semi-quantitative assessment of perfusion deficits that correlate with qualitative assessment.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Myocardial stress perfusion magnetic resonance: initial experience in a pediatric and young adult population using regadenoson
    Noel, Cory V.
    Krishnamurthy, Ramkumar
    Moffett, Brady
    Krishnamurthy, Rajesh
    PEDIATRIC RADIOLOGY, 2017, 47 (03) : 280 - 289
  • [22] Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
    Javier Muñiz-Sáenz-Diez
    Ana Ezponda
    Meylin Caballeros
    Ana de la Fuente
    Juan J. Gavira
    Gorka Bastarrika
    The International Journal of Cardiovascular Imaging, 2023, 39 : 1765 - 1774
  • [23] Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis
    Palani, Gurunanthan
    Husain, Zehra
    Salinas, Rafael Cabrera
    Karthikeyan, Vanji
    Karthikeyan, Aarthee S.
    Ananthasubramaniam, Karthik
    JOURNAL OF NUCLEAR CARDIOLOGY, 2011, 18 (04) : 605 - 611
  • [24] Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
    Muniz-Saenz-Diez, Javier
    Ezponda, Ana
    Caballeros, Meylin
    de la Fuente, Ana
    Gavira, Juan J.
    Bastarrika, Gorka
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2023, 39 (09): : 1765 - 1774
  • [25] One year major cardiac outcomes after normal and abnormal regadenoson stress myocardial perfusion imaging
    Ananthasubramaniam, Karthikeyan
    Husain, Zehra
    Cabrera, Rafael
    Palani, Gurunanthan
    Karthikeyan, Aarthee
    Choudhry, Zain
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [26] Safety and tolerability of regadenoson for myocardial perfusion imaging - first Danish experience
    Pape, Marianne
    Zacho, Helle D.
    Aaroe, Jens
    Jensen, Svend Eggert
    Petersen, Lars J.
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2016, 50 (03) : 180 - 186
  • [27] Correcting curvilinear myocardial signal response to gadolinium improves accuracy of absolute myocardial blood flow quantification by MRI perfusion Imaging
    Lee, Daniel C.
    Johnson, Nils P.
    O'Hara, Kelly C.
    Harris, Kathleen R.
    CIRCULATION, 2007, 116 (16) : 426 - 426
  • [28] Safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic kidney disease patients not on hemodialysis
    Gurunanthan Palani
    Zehra Husain
    Rafael Cabrera Salinas
    Vanji Karthikeyan
    Aarthee S. Karthikeyan
    Karthik Ananthasubramaniam
    Journal of Nuclear Cardiology, 2011, 18 : 605 - 611
  • [29] Comparison of hemodynamic and stress testing variables in patients undergoing regadenoson stress myocardial perfusion imaging to regadenoson with adjunctive low-level exercise myocardial perfusion imaging
    Cabrera, Rafael
    Husain, Zehra
    Palani, Gurunanthan
    Karthikeyan, Aarthee S.
    Choudhry, Zain
    Dhanalakota, Sunita
    Peterson, Ed.
    Ananthasubramaniam, Karthik
    JOURNAL OF NUCLEAR CARDIOLOGY, 2013, 20 (03) : 336 - 343
  • [30] Stress perfusion Cardiac MRI: a new tool in the evaluation of myocardial ischemia
    Marques, Hugo
    Cardim, Nuno
    Teixeira, Ruben
    da Mariana, Sylvie
    Gaspar, Augusto
    Machado, Francisco Pereira
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2010, 29 (09) : 1437 - 1439